Main Article Content
Contraceptive Agents, Contraception, Counseling, Professional Practice, Community Pharmacy Services, Pharmacies, Pharmacists, Quality of Health Care, Patient Simulation, United Arab Emirates
Background: Hormonal contraceptive pills have evolved as a common form of contraception worldwide. Pharmacists play a vital role in providing safe and effective access to these medicines. In many developing countries such as the United Arab Emirates (UAE), these medicines are available to the general public without the presentation of a prescription which requires the pharmacist to shoulder responsibility by assessing and educating patients to assure their appropriate use.
Objectives: To evaluate community pharmacists’ current practice of dispensing and counseling on hormonal contraceptives
Methods: Simulated patient methodology was used in this study. A single simulated patient visited community pharmacies requesting an oral contraceptive as per a preplanned scenario. Information from the visits were recorded on a data collection form including: pharmacist assessing patient eligibility to take hormonal contraceptives, selecting the appropriate oral contraceptive, providing complete counseling on how to use the pill, adherence, missed dose handlings and side effects of the medication. The Pharmacist was prompted by the simulated patient to provide the information if they did not provide spontaneous counseling. The quality of pharmacists’ counseling was rated and consequently coded as complete, incomplete or poor.
Results: A total of 201 community pharmacies were visited. More than 92% of the pharmacists did not ask the simulated patient any question to assess their eligibility to use contraceptives. Twenty three pharmacists (11.4%) selected the proper product. One hundred seventeen (58.2%) of the pharmacists provided spontaneous counseling on how to use the pill, 17 of them had their counsel rated as complete, but none of the pharmacists provided spontaneous counseling regarding adherence or side effects of the medications. On prompting, 10 pharmacists (12%) provided complete counseling regarding how to use oral contraceptives, 14 pharmacists (7.0%) provided complete counseling on adherence and missing dose handling and five pharmacists (2.5%) provided complete counseling about expected side effects.
Conclusions: Pharmacists’ practice regarding hormonal contraceptive dispensing and counseling was suboptimal in this study. Areas needing intervention were related to pharmacist assessment of eligibility for oral contraceptive use, choice of optimal oral contraceptive for patient-specific co-morbidities and provision of adequate counseling regarding proper use, adherence and missed dose handlings.
2. WHO | Family planning/Contraception. Available at: http://www.who.int/mediacentre/factsheets/fs351/en/ (accessed Feb 5, 2019).
3. Family Planning - Model - United Nations Population Division | Department of Economic and Social Affairs. Available at: http://www.un.org/en/development/desa/population/theme/family-planning/cp_model.shtml (accessed Feb 5, 2019).
4. Schindler AE. Non-contraceptive benefits of oral hormonal contraceptives. Int J Endocrinol Metab. 2013;11(1):41-47. https://doi.org/10.5812/ijem.4158
5. Brynhildsen J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Ther Adv Drug Saf. 2014;5(5):201-213. https://doi.org/10.1177/2042098614548857
6. Wolski H. [Selected aspects of oral contraception side effects]. Ginekol Pol. 2014;85(12):944-999.
7. Sonfield A, Kost K, Gold RB, Finer LB. The public costs of births resulting from unintended pregnancies: national and state-level estimates. Perspect Sex Reprod Health. 2011;43(2):94-102. https://doi.org/10.1363/4309411
8. World Health Organization. Reproductive Health and Research, World Health Organization. Medical eligibility criteria for contraceptive use. Geneva: WHO; 2015.
9. Peter LM, DiPietro NA. Pharmacists’ Provision of Contraception: Established and Emerging Roles. Innov Pharm. 2016;7(3):15.
10. McIntosh J, Rafie S, Wasik M, McBane S, Lodise NM, El-Ibiary SY, Forinash A, Kachlic MD, Rowe E, Besinque K. Changing oral contraceptives from prescription to over-the-counter status: an opinion statement of the Women’s Health Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011;31(4):424-437. https://doi.org/10.1592/phco.31.4.424
11. How Oregon Pharmacists Are Prescribing Birth Control [Internet]. Available at: http://www.pharmacytimes.com/resource-centers/womens-health/how-oregon-pharmacists-are-prescribing-birth-control (accessed Feb 5, 2019).
12. Gardner JS, Miller L, Downing DF, Le S, Blough D, Shotorbani S. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J Am Pharm Assoc (2003). 2008;48(2):212-221. https://doi.org/10.1331/JAPhA.2008.07138
13. NHS. Evaluation of Oral Contraception in Community Pharmacy Pilot in Southwark and Lambeth. Available at: http://ocsotc.org/wp-content/uploads/2012/04/NHS-2012_Evaluation-of-pharmacy-provision-of-OCs-in-London-1-2012.pdf (accessed Feb 5, 2019).
14. Obreli-Neto PR, Pereira LRL, Guidoni CM, de Oliveira Baldoni A, Marusic S, de Lyra-Júnior DP, de Almeida KL, Pazete AC, do Nascimento JD, Kos M, Girotto E, Cuman RK. Use of simulated patients to evaluate combined oral contraceptive dispensing practices of community pharmacists. PLoS One. 2013;8(12):e79875. https://doi.org/10.1371/journal.pone.0079875
15. Ratanajamit C, Chongsuvivatwong V. Survey of knowledge and practice on oral contraceptive and emergency contraceptive pills of drugstore personnel in Hat Yai, Thailand. Pharmacoepidemiol Drug Saf. 2001;10(2):149-156. https://doi.org/10.1002/pds.573
16. Becker D, Garcia SG, Ellertson C. Do Mexico City pharmacy workers screen women for health risks when they sell oral contraceptive pills over-the-counter? Contraception. 2004;69(4):295-299. https://doi.org/10.1016/j.contraception.2003.11.014
17. Foroutan N, Dabaghzadeh F. Evaluating the practice of Iranian community pharmacists regarding oral contraceptive pills using simulated patients. Pharm Pract (Granada). 2016;14(4):745. https://doi.org/10.18549/PharmPract.2016.04.745
18. Cleland JA, Abe K, Rethans JJ. The use of simulated patients in medical education: AMEE Guide No 42. Med Teach. 2009;31(6):477-486.
19. Weiner SJ, Schwartz A. Directly Observed Care: Can Unannounced Standardized Patients Address a Gap in Performance Measurement? J Gen Intern Med. 2014;29(8):1183-1187. https://doi.org/10.1007/s11606-014-2860-7
20. Dubai Community Pharmacy Licensure and Pharmaceutical Practices Guide. Available at: https://www.dha.gov.ae/Documents/Regulations/Dubai%20Community%20Pharmacy%20Licensure%20and%20Pharmaceutical%20Practices%20Guide.pdf (accessed Feb 5, 2019).
21. Nappi RE, Merki-Feld GS, Terreno E, Pellegrinelli A, Viana M. Hormonal contraception in women with migraine: is progestogen-only contraception a better choice? J Headache Pain. 2013;14:66. https://doi.org/10.1186/1129-2377-14-66
22. The progestogen-only pill - NHS.UK. Available at: https://www.nhs.uk/conditions/contraception/the-pill-progestogen-only/ (accessed Feb 5, 2019).
23. UAE has over 2000 private pharmacies, 4000 professionals. Available at: http://wam.ae/en/details/1395228626943 (accessed Feb 5, 2019).
24. Standard Procedures Algorithm For RPH Prescribing Of Hormonal Contraceptives. Available at: https://www.oregon.gov/pharmacy/Imports/ContraceptivePrescribing/ORStandardProceduresAlgorithmForRPHPrescribingOfHormonalContraceptives11_2015.pdf (accessed Feb 5, 2019).
25. Rodriguez MI, McConnell KJ, Swartz J, Edelman AB. Pharmacists prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision. J Am Pharm Assoc (2003). 2016;56(5):521-526. https://doi.org/10.1016/j.japh.2016.05.003
26. Sacco S, Ornello R, Ripa P, Pistoia F, Carolei A. Migraine and hemorrhagic stroke: a meta-analysis. Stroke. 2013;44(11):3032-3038. https://doi.org/10.1161/STROKEAHA.113.002465
27. Etminan M, Takkouche B, Isorna FC, Samii A. Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies. BMJ. 2005;330(7482):63. https://doi.org/10.1136/bmj.38302.504063.8F
28. Dehlendorf C, Krajewski C, Borrero S. Contraceptive counseling: best practices to ensure quality communication and enable effective contraceptive use. Clin Obstet Gynecol. 2014;57(4):659-673. https://doi.org/10.1097/GRF.0000000000000059
29. Hasan S, Sulieman H, Chapman C, Stewart K, Kong DC. Community pharmacy in the United Arab Emirates: characteristics and workforce issues. Int J Pharm Pract. 2011;19(6):392-399. https://doi.org/10.1111/j.2042-7174.2011.00134.x
30. El Hajj MS, Hammad AS, Afifi HM. Pharmacy students’ attitudes toward pharmaceutical care in Qatar. Ther Clin Risk Manag. 2014;10:121-129. https://doi.org/10.2147/TCRM.S56982
31. WHO. United Arab Emirates. Available at: http://www.who.int/countries/are/en/ (accessed Feb 5, 2019).
32. Hasan S, Sulieman H, Chapman CB, Stewart K, Kong DC. Community pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2012;20(4):218-225. https://doi.org/10.1111/j.2042-7174.2011.00182.x
33. Parsons J, Adams C, Aziz N, Holmes J, Jawad R, Whittlesea C. Evaluation of a community pharmacy delivered oral contraception service. J Fam Plann Reprod Health Care. 2013;39(2):97-101. https://doi.org/10.1136/jfprhc-2012-100304
34. Watson MC, Norris P, Granas AG. A systematic review of the use of simulated patients and pharmacy practice research. Int J Pharm Pract. 2006;14(2):83-93. https://doi.org/10.1211/ijpp.14.2.0002